Drug intelligence / Profile preview

Balanil

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Topical
01

Overview

Balanil is a topical therapeutic product line developed by Epitech, available in formulations such as Balanil Gel and Balanil Lavaggio (wash). The primary active ingredient is **adelmidrol**, a synthetic analogue of the endogenous fatty acid amide palmitoylethanolamide (PEA). Adelmidrol belongs to the **ALIAmide** (Autacoid Local Inflammation Antagonism) class, which acts by modulating the activation and degranulation of **mast cells** and other non-neuronal immune cells. By stabilizing these cells, Balanil reduces the release of pro-inflammatory and pro-algesic mediators, thereby addressing localized neuro-inflammation and pain. It is primarily indicated for urological and dermatological conditions affecting the male genital area, including **balanitis**, **balanoposthitis**, and the management of symptoms associated with **prostatitis**, **benign prostatic hyperplasia (BPH)**, and **lower urinary tract symptoms (LUTS)**.

Brand names
BalanilBalanil GelBalanil Lavaggio
Other names
Balanil GelBalanil Lavaggio

Beyond the preview

Go deeper on Balanil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Balanil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call